Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Universitaet Des Saarlandes
Sponsor

Universitaet Des Saarlandes

Germany Kirrberger Strasse 100, 66421 Homburg, Germany

About the sponsor

Clinical research activity includes diffuse large B-cell lymphoma and related aggressive B-cell lymphoma subtypes, with interest in both standard and biologically defined entities such as primary cutaneous DLBCL, intravascular large B-cell lymphoma, EBV-positive DLBCL, and high-grade B-cell lymphoma.

  • Diffuse large B-cell lymphoma
  • Primary cutaneous lymphoma
  • High-grade B-cell lymphoma

Additional focus extends to rarer lymphoma presentations, including primary mediastinal large B-cell lymphoma, follicular lymphoma grade 3B, and T-cell/histiocyte-rich large B-cell lymphoma.

About Specializations

Universitaet Des Saarlandes runs clinical trials in conditions such as Squamous cell carcinoma of the oral cavity, Squamous cell carcinoma of the hypopharynx, Laryngeal squamous cell carcinoma, Oropharyngeal cancer recurrent, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

5 clinical trials

Squamous cell carcinoma of the oral cavity+3

Recruiting

Study on Pembrolizumab and Drug Combination for Patients with Recurrent Head and Neck Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Universitaet Des Saarlandes

Double hit lymphoma+7

Recruiting

Study on Acalabrutinib with Rituximab and Drug Combination for Older Adults with Untreated Diffuse Large B-Cell Lymphoma

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Universitaet Des Saarlandes

Small cell lung cancer extensive stage+1

Recruiting

Study of Durvalumab, Cisplatin, Carboplatin, and Etoposide for Patients with Extensive Stage Small Cell Lung Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Universitaet Des Saarlandes

Squamous cell carcinoma of the oral cavity+3

Not recruiting

Study of Pembrolizumab with Lenvatinib after Chemoradiation Treatment in Patients with Locally Advanced Head and Neck Cancer who are PD-L1 Positive

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Lenvatinib
  • Sponsor:Universitaet Des Saarlandes

Prostate cancer

Not recruiting

Study on Apalutamide and Hormone Therapy Before Surgery for Patients with Advanced High-Risk Prostate Cancer

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Apalutamide
  • Sponsor:Universitaet Des Saarlandes

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.